Skip to content

Clinical trials

Phase 2 Renal Insufficiency, Chronic trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Renal Insufficiency, Chronic Phase: Phase 2 Country / region: China Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20121
20141
20161
20181
20212
20222
20231
20244
20254
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Not yet recruiting3
Recruiting2
Unknown status2
Withdrawn2
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim4
Jiangsu Hansoh Pharmaceutical Co., Ltd.2
Shenzhen Salubris Pharmaceuticals Co., Ltd.2
Alebund Pharmaceuticals1
AstraZeneca1
Atom Therapeutics Co., Ltd1
Bayer1
Bing Shu1
Eli Lilly and Company1
Guang'anmen Hospital of China Academy of Chinese Medical Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Renal Insufficiency, Chronic22
Anemia2
Carcinoma, Renal Cell1
Chronic Kidney Disease-Mineral and Bone Disorder1
Glomerulonephritis, IGA1
Hyperphosphatemia1
Kidney Failure, Chronic1
Kidney Neoplasms1
Nephrotic Syndrome1
Obesity1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.